| Daniel Peter Alyea, MD | |
|
339 Consort Dr, Ballwin, MO 63011-4439 | |
| (636) 386-9224 | |
| Not Available |
| Full Name | Daniel Peter Alyea |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 40 Years |
| Location | 339 Consort Dr, Ballwin, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376614685 | NPI | - | NPPES |
| 036086822001 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 036086822 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alton Memorial Hospital | Alton, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Anesthesia Providers Sc | 9830480581 | 139 |
News Archive
Tranzyme Pharma announced positive top-line results today from a Phase 2, double-blind, placebo-controlled study evaluating TZP-102 capsules in diabetic patients with gastroparesis, a serious disorder characterized by the inability of the stomach to empty food efficiently. The study achieved a clinically meaningful and statistically significant improvement in critical gastroparesis-related symptoms. All three TZP-102 doses tested were effective, safe and well tolerated.
Building on the success and popularity of REALIZE mySUCCESS(R) for REALIZE(TM) Band patients, Ethicon Endo-Surgery, Inc. announced today it will expand availability of the Web-based clinical support tool to gastric bypass and sleeve gastrectomy patients.
Family caregivers of the deceased rated the quality of end-of-life care in the intensive care unit (ICU) higher than the end-of-life care in other hospital departments (also called wards), according to new, large Penn Medicine study in the American Journal of Respiratory and Critical Care Medicine.
The University of Colorado Denver and assistant psychology professor Dr. Amy Wachholtz were awarded more than $700,000 in funding by the National Institute of Health (NIH) to study treatments for chronic pain sufferers who become addicted to opioids. Recruitment is underway to enroll study patients for this clinical research.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has announced the completion of enrollment in its Phase IIb imm01 clinical trial of V5 in tuberculosis.
› Verified 5 days ago
| Entity Name | Normal Bloomington Anesthesiologists, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760754378 PECOS PAC ID: 4385806181 Enrollment ID: O20120424000098 |
News Archive
Tranzyme Pharma announced positive top-line results today from a Phase 2, double-blind, placebo-controlled study evaluating TZP-102 capsules in diabetic patients with gastroparesis, a serious disorder characterized by the inability of the stomach to empty food efficiently. The study achieved a clinically meaningful and statistically significant improvement in critical gastroparesis-related symptoms. All three TZP-102 doses tested were effective, safe and well tolerated.
Building on the success and popularity of REALIZE mySUCCESS(R) for REALIZE(TM) Band patients, Ethicon Endo-Surgery, Inc. announced today it will expand availability of the Web-based clinical support tool to gastric bypass and sleeve gastrectomy patients.
Family caregivers of the deceased rated the quality of end-of-life care in the intensive care unit (ICU) higher than the end-of-life care in other hospital departments (also called wards), according to new, large Penn Medicine study in the American Journal of Respiratory and Critical Care Medicine.
The University of Colorado Denver and assistant psychology professor Dr. Amy Wachholtz were awarded more than $700,000 in funding by the National Institute of Health (NIH) to study treatments for chronic pain sufferers who become addicted to opioids. Recruitment is underway to enroll study patients for this clinical research.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has announced the completion of enrollment in its Phase IIb imm01 clinical trial of V5 in tuberculosis.
› Verified 5 days ago
| Entity Name | Midwest Anesthesia Providers Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295189082 PECOS PAC ID: 9830480581 Enrollment ID: O20160628000182 |
News Archive
Tranzyme Pharma announced positive top-line results today from a Phase 2, double-blind, placebo-controlled study evaluating TZP-102 capsules in diabetic patients with gastroparesis, a serious disorder characterized by the inability of the stomach to empty food efficiently. The study achieved a clinically meaningful and statistically significant improvement in critical gastroparesis-related symptoms. All three TZP-102 doses tested were effective, safe and well tolerated.
Building on the success and popularity of REALIZE mySUCCESS(R) for REALIZE(TM) Band patients, Ethicon Endo-Surgery, Inc. announced today it will expand availability of the Web-based clinical support tool to gastric bypass and sleeve gastrectomy patients.
Family caregivers of the deceased rated the quality of end-of-life care in the intensive care unit (ICU) higher than the end-of-life care in other hospital departments (also called wards), according to new, large Penn Medicine study in the American Journal of Respiratory and Critical Care Medicine.
The University of Colorado Denver and assistant psychology professor Dr. Amy Wachholtz were awarded more than $700,000 in funding by the National Institute of Health (NIH) to study treatments for chronic pain sufferers who become addicted to opioids. Recruitment is underway to enroll study patients for this clinical research.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has announced the completion of enrollment in its Phase IIb imm01 clinical trial of V5 in tuberculosis.
› Verified 5 days ago
| Entity Name | Midwest Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558719617 PECOS PAC ID: 8921387390 Enrollment ID: O20161221000252 |
News Archive
Tranzyme Pharma announced positive top-line results today from a Phase 2, double-blind, placebo-controlled study evaluating TZP-102 capsules in diabetic patients with gastroparesis, a serious disorder characterized by the inability of the stomach to empty food efficiently. The study achieved a clinically meaningful and statistically significant improvement in critical gastroparesis-related symptoms. All three TZP-102 doses tested were effective, safe and well tolerated.
Building on the success and popularity of REALIZE mySUCCESS(R) for REALIZE(TM) Band patients, Ethicon Endo-Surgery, Inc. announced today it will expand availability of the Web-based clinical support tool to gastric bypass and sleeve gastrectomy patients.
Family caregivers of the deceased rated the quality of end-of-life care in the intensive care unit (ICU) higher than the end-of-life care in other hospital departments (also called wards), according to new, large Penn Medicine study in the American Journal of Respiratory and Critical Care Medicine.
The University of Colorado Denver and assistant psychology professor Dr. Amy Wachholtz were awarded more than $700,000 in funding by the National Institute of Health (NIH) to study treatments for chronic pain sufferers who become addicted to opioids. Recruitment is underway to enroll study patients for this clinical research.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has announced the completion of enrollment in its Phase IIb imm01 clinical trial of V5 in tuberculosis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Peter Alyea, MD 339 Consort Dr, Credentialing Department, Ballwin, MO 63011-4439 Ph: (636) 386-9224 | Daniel Peter Alyea, MD 339 Consort Dr, Ballwin, MO 63011-4439 Ph: (636) 386-9224 |
News Archive
Tranzyme Pharma announced positive top-line results today from a Phase 2, double-blind, placebo-controlled study evaluating TZP-102 capsules in diabetic patients with gastroparesis, a serious disorder characterized by the inability of the stomach to empty food efficiently. The study achieved a clinically meaningful and statistically significant improvement in critical gastroparesis-related symptoms. All three TZP-102 doses tested were effective, safe and well tolerated.
Building on the success and popularity of REALIZE mySUCCESS(R) for REALIZE(TM) Band patients, Ethicon Endo-Surgery, Inc. announced today it will expand availability of the Web-based clinical support tool to gastric bypass and sleeve gastrectomy patients.
Family caregivers of the deceased rated the quality of end-of-life care in the intensive care unit (ICU) higher than the end-of-life care in other hospital departments (also called wards), according to new, large Penn Medicine study in the American Journal of Respiratory and Critical Care Medicine.
The University of Colorado Denver and assistant psychology professor Dr. Amy Wachholtz were awarded more than $700,000 in funding by the National Institute of Health (NIH) to study treatments for chronic pain sufferers who become addicted to opioids. Recruitment is underway to enroll study patients for this clinical research.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has announced the completion of enrollment in its Phase IIb imm01 clinical trial of V5 in tuberculosis.
› Verified 5 days ago
Tammara S Goldschmidt, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 339 Consort Dr, Ballwin, MO 63011 Phone: 636-386-9224 Fax: 636-386-7679 | |
Dr. Patrick M D'souza, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 339 Consort Dr, Ballwin, MO 63011 Phone: 636-386-9224 Fax: 636-386-7679 | |
Dr. Jeffrey Alexander, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 351 Consort Dr, Ballwin, MO 63011 Phone: 636-200-4242 Fax: 636-200-4243 | |
Dr. Matthew H Bigham, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 339 Consort Dr, Ballwin, MO 63011 Phone: 636-386-9224 Fax: 636-386-7679 | |
Matthew Casey, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 339 Consort Dr, Ballwin, MO 63011 Phone: 636-386-9224 Fax: 636-386-7679 | |
Elizabeth Cohen, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 339 Consort Dr, Ballwin, MO 63011 Phone: 636-386-9224 |